KIMBERLY POLK: Open Payments
NPI 1730411059 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 73 payments from 15 companies in 2025. Trend: 2023 $1,423 · 2024 $1,536 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $334 |
| Novo Nordisk Inc | 13 | $228 |
| GlaxoSmithKline, LLC. | 14 | $193 |
| ABBVIE INC. | 11 | $185 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $141 |
| Amgen Inc. | 3 | $66 |
| Lilly USA, LLC | 3 | $48 |
| Abbott Laboratories | 2 | $43 |
| ABIOMED | 1 | $29 |
| Boston Scientific Corporation | 1 | $28 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, LINZESS, JARDIANCE, Ozempic, BREZTRI, OTEZLA, Rybelsus.
Industry payments across TN — which companies pay providers there.
